Lars Jacobsen

7.8k total citations · 2 hit papers
58 papers, 4.4k citations indexed

About

Lars Jacobsen is a scholar working on Immunology and Allergy, Physiology and Dermatology. According to data from OpenAlex, Lars Jacobsen has authored 58 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Immunology and Allergy, 26 papers in Physiology and 20 papers in Dermatology. Recurrent topics in Lars Jacobsen's work include Allergic Rhinitis and Sensitization (31 papers), Asthma and respiratory diseases (25 papers) and Dermatology and Skin Diseases (18 papers). Lars Jacobsen is often cited by papers focused on Allergic Rhinitis and Sensitization (31 papers), Asthma and respiratory diseases (25 papers) and Dermatology and Skin Diseases (18 papers). Lars Jacobsen collaborates with scholars based in Denmark, Germany and France. Lars Jacobsen's co-authors include Erkka Valovirta, Ulrich Wahn, A. Koivikko, B. Niggemann, Arne Høst, Susanne Halken, Sten Dreborg, Hosne Ara Ferdousi, Lene Annette Norberg and C. Møller and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, British journal of surgery and British Journal of Anaesthesia.

In The Last Decade

Lars Jacobsen

57 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study)

2002 745 citations Christian Möller, Sten Dreborg et al. Journal of Allergy and Clinical Immunology profile →
Specific immunotherapy has long‐term preventive effect of seasonal and perennial asthma: 10‐year follow‐up on the PAT study

2007 691 citations Lars Jacobsen, B. Niggemann et al. Allergy profile →

Peers

Countries citing papers authored by Lars Jacobsen

Since Specialization

Citations

This map shows the geographic impact of Lars Jacobsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Jacobsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Jacobsen more than expected).

Fields of papers citing papers by Lars Jacobsen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Jacobsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Jacobsen. The network helps show where Lars Jacobsen may publish in the future.

Co-authorship network of co-authors of Lars Jacobsen

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Jacobsen. A scholar is included among the top collaborators of Lars Jacobsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Jacobsen. Lars Jacobsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Quantification of HER2-low and ultra-low expression in breast cancer specimens by quantitative IHC and artificial intelligence 2025 ·Journal of Pathology Informatics ·(unknown), (unknown), Itay Remer, Oded Ben-David, Amir Ben‐Dor, (unknown), (unknown), (unknown), Sarit Aviel‐Ronen, (unknown), Jens Mollerup, Lars Jacobsen, Anya Tsalenko	2
2	Feasibility of prehospital identification of non-ST-elevation myocardial infarction by ECG, troponin and echocardiography 2022 ·Emergency Medicine Journal ·Lars Jacobsen, Bjørnar Grenne, Roy Bjørkholt Olsen, Jarle Jortveit	7
3	State‐of‐the‐art in marketed adjuvants and formulations in Allergen Immunotherapy: A position paper of the European Academy of Allergy and Clinical Immunology (EAACI) 2019 ·Allergy ·Erika Jensen‐Jarolim, Martin F. Bachmann, С. Бонини, Lars Jacobsen, Marek Jutel, Ludger Klimek, Vera Mahler, Ralph Mösges, Philippe Moingeon, (unknown), Óscar Palomares, Oliver Pfaar, Harald Renz, Claudio Rhyner, Franziska Roth‐Walter, Michael Rudenko, J. Savolainen, Carsten B. Schmidt‐Weber, Claudia Traidl‐Hoffmann, Thomas M. Kündig	49
4	Efficacy of 2 months of allergen-specific immunotherapy with Bet v 1–derived contiguous overlapping peptides in patients with allergic rhinoconjunctivitis: Results of a phase IIb study 2016 ·Journal of Allergy and Clinical Immunology ·François Spertini, (unknown), Alexander Kettner, F. de Blay, Lars Jacobsen, Marek Jutel, Margitta Worm, Vincent Charlon, Christophe Reymond	50
5	Comparison of allergen immunotherapy practice patterns in the United States and Europe 2009 ·Annals of Allergy Asthma & Immunology ·Linda Cox, Lars Jacobsen	129
6	How strong is the evidence that immunotherapy in children prevents the progression of allergy and asthma? 2007 ·Current Opinion in Allergy and Clinical Immunology ·Lars Jacobsen, Erkka Valovirta	28
7	Specific immunotherapy has long‐term preventive effect of seasonal and perennial asthma: 10‐year follow‐up on the PAT study breakdown → 2007 ·Allergy ·Lars Jacobsen, B. Niggemann, Sten Dreborg, Hosne Ara Ferdousi, Susanne Halken, Arne Høst, A. Koivikko, Lene Annette Norberg, Erkka Valovirta, Ulrich Wahn, C. Møller, (unknown)	691
8	Sublingual immunotherapy in children modulates allergen‐induced in vitro expression of cytokine mRNA in PBMC 2006 ·Allergy ·J. Savolainen, Lars Jacobsen, Erkka Valovirta	75
9	Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children 2006 ·Allergy ·Erkka Valovirta, Lars Jacobsen, Christian Ljørring, A. Koivikko, J. Savolainen	105
10	Five‐year follow‐up on the PAT study: specific immunotherapy and long‐term prevention of asthma in children 2006 ·Allergy ·B. Niggemann, Lars Jacobsen, Sten Dreborg, Hosne Ara Ferdousi, Susanne Halken, Arne Høst, A. Koivikko, Daniela Koller, Lene Annette Norberg, R. Urbanek, Erkka Valovirta, Ulrich Wahn, C. Møller, (unknown)	224
11	Intubation conditions after rocuronium or succinylcholine for rapid sequence induction with alfentanil and propofol in the emergency patient 2005 ·European Journal of Anaesthesiology ·Per Larsen, (unknown), Lars Jacobsen, (unknown), Peter Johannes Holst, (unknown), (unknown), Hans H. Wittrup, Anne Mette Skov Sørensen, Sara Persson, J. Engbæk	28
12	Analgesic effect of i.v. paracetamol: possible ceiling effect of paracetamol in postoperative pain 2003 ·Acta Anaesthesiologica Scandinavica ·Tae Won Hahn, T. Mogensen, Christian Lund, Lars Jacobsen, (unknown), Søren N. Rasmussen, Martin Kaag Rasmussen	60
13	Preventive aspects of specific immunotherapy. 2003 ·PubMed ·Lars Jacobsen	1
14	Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study) breakdown → 2002 ·Journal of Allergy and Clinical Immunology ·Christian Möller, Sten Dreborg, Hosne Ara Ferdousi, Susanne Halken, Arne Høst, Lars Jacobsen, A. Koivikko, Dieter Y. Koller, B. Niggemann, Lene Annette Norberg, R. Urbanek, Erkka Valovirta, Ulrich Wahn	745
15	Preventive aspects of immunotherapy: prevention for children at risk of developing asthma 2001 ·Annals of Allergy Asthma & Immunology ·Lars Jacobsen	40
16	A double-blinded, comparative study of the effects of short preseason specific immunotherapy and topical steroids in patients with allergic rhinoconjunctivitis and asthma 2001 ·Journal of Allergy and Clinical Immunology ·S. Rak, Christina Heinrich, Lars Jacobsen, Annika Scheynius, Per Venge	52
17	A 1‐year, placebo‐controlled, double‐blind house‐dust‐mite immunotherapy study in asthmatic adults 1997 ·Allergy ·(unknown), Klaus Richter Larsen, Lars Jacobsen, U. G. Svendsen	80
18	Comparison of three immunoassays for diagnosing sensitization to latex in children with spina bifida 1996 ·Pediatric Allergy and Immunology ·B. Niggemann, (unknown), (unknown), Ulrich Seidel, R. Wahl, Lars Jacobsen, Débora da Luz Scheffer, Ulrich Wahn	7
19	A controlled dose-response study of immunotherapy with standardized, partially purified extract of house dust mite: Clinical efficacy and side effects 1993 ·Journal of Allergy and Clinical Immunology ·L. Haugaard, Ronald E. Dahl, Lars Jacobsen	147
20	Low dose x-irradiation and teratogenesis. A quantitative experimental study, with reference to seasonal influence on dose effects. 1968 ·The Mouseion at the JAXlibrary (Jackson Laboratory) ·Lars Jacobsen	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact